Clinical Trial Update: The Swiss Venous Thromboembolism Cohort 65+

View source ↗

Summary

The Swiss Venous Thromboembolism Cohort 65+ trial conducted by the University of Lausanne Hospitals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: University of Lausanne Hospitals | Conditions: Venous Thromboembolism | Status: COMPLETED